Primary Site >> Liver Cancer
Gene >> CA9
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Detectability and diagnostic criteria of p53 gene mutations in human oral squamous cell carcinoma using yeast functional assay]. PMID: 9145313 |
Ref: Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. PMID: 15596295 |
Ref: Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer. PMID: 16242253 |
Ref: Cytotoxic lignan esters from Cinnamomum osmophloeum. PMID: 19950049 Ref: CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1alpha in Hepatoma Cells. PMID: 21165333 |
Ref: Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro. PMID: 22724087 |
Ref: Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study. PMID: 23362324 Ref: Disulfiram deregulates HIF-alpha subunits and blunts tumor adaptation to hypoxia in hepatoma cells. PMID: 23852087 |
Ref: Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. PMID: 25425262 |
Ref: Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. PMID: 27312064 |
Ref: 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma. PMID: 28667334 Ref: Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelialmesenchymal transition in hepatocellular carcinoma. PMID: 28849188 Ref: Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study. PMID: 29245907 |
Ref: pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma. PMID: 29900055 Ref: Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis. PMID: 29938458 Ref: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis. PMID: 30011326 Ref: A Phase II and Biomarker Study of Sorafenib Combined with FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC). PMID: 30190369 Ref: Glucose and glutamine availability regulate HepG2 transcriptional responses to low oxygen. PMID: 30345392 |